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Abstract 
The Effects of Feeding Growing Female Rats Different Sources of Omega-3 
Polyunsaturated Fatty Acids on Lipogenic Gene Expression and Lipid Metabolism in Liver 
and Adipose Tissues 
Kaitlin Mock 
 
Omega-3 polyunsaturated fatty acid (n-3 PUFA) consumption has increased through diet 
and supplementation due to reports of health benefits. The objective of this study was to 
determine whether different n-3 PUFA sources play a role in lipid metabolism by altering 
lipogenic gene expression, serum lipids and lipoproteins, and inflammation.  Young (aged 28 
days) female Sprague-Dawley rats were assigned to one of six diets: corn oil (CO, control), 
flaxseed oil (FO), krill oil (KO), menhaden oil (MO), salmon oil (SO), or tuna oil (TO).  qPCR 
was used to analyze relative gene expression.  Only MO-fed rats had down-regulated gene 
expression of the lipogenic transcription factor sterol regulatory element binding protein 1c 
(SREBP-1c) (P=0.007), and downstream enzymes, fatty acid synthase (FAS) (P=0.001) and 
stearoyl coenzyme A desaturase 1(SCD-1) (P=0.008).  MO-fed rats had lower (P<0.001) hepatic 
arachidonic acid (ARA) content compared to rats fed SO, TO, and CO.  Rats fed all n-3 PUFA 
sources had down-regulated FAS gene expression, except KO.  There were no significant 
changes in expression of lipogenic genes in the hepatic tissue of rats fed KO.  Only TO, with the 
lowest eicosapentaenoic acid:docosahexaenoic acid (EPA:DHA) ratio in hepatic tissue, down-
regulated  SCD-1 gene expression.  In the gonadal adipose tissue, FO was the only oil source to 
alter lipolytic gene expression.  PPARγ was up-regulated in FO (P=0.04) compared to CO-fed 
rats.  FO had the highest (P<0.05) EPA:DHA ratio in gonadal adipose tissue.  All n-3 PUFA 
sources decreased lipogenesis, evidenced by decreased (P<0.05) serum high density lipoprotein 
(HDL-C), and marine sources of n-3 PUFAs decreased (P<0.05) serum total cholesterol (CHL).  
Higher dietary 18:1 may be transported to extrahepatic tissues as indicated by the absence of 
decreased (P>0.05) serum total CHL in FO.  All n-3 LC-PUFA sources altered inflammation 
related hepatic Inhibitor of Kappa B alpha (IKBα) gene expression, except the MO group which 
was the only n-3 PUFA that down-regulated lipogenic transcription factor SREBP-1c.  Based on 
the study results, the MO diet caused a low hepatic ARA content and subsequently affected 
lipogenic gene expression the most; high EPA and DHA content in the SO and TO diets caused 
the most decrease in circulating lipids; and all n-3 PUFAs affected gene expression related to 
inflammation, except for the MO diet group which altered the transcription factor SREBP-1c.  
Therefore, different sources of n-3 PUFAs had different effects on lipogenesis and lipolysis gene 
expression which affects lipid metabolism indicated by reduced circulating lipids and 
lipoproteins, and inflammation which may play a role in cardiovascular disease (CVD) risk.
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1.0 Introduction 
Omega-3 polyunsaturated fatty acid (n-3 PUFA) consumption has been reported to 
provide many health benefits, particularly the potential to decrease cardiovascular disease 
(CVD)-related events.  In a human study, Skulas-Ray et al. (1) found that subjects provided 
eicosapentaenoic acid (EPA, 20:5n-3) and docosahexaenoic acid (DHA, 22:6n-3) (3.4 g per day), 
for 8 weeks significantly decreased serum triglyceride (TG) levels compared to subjects provided 
corn oil (CO).  However, the effects of n-3 PUFA supplementation on serum lipids and 
lipoproteins have been inconsistent (2).  Therefore, the health benefits of n-3 PUFAs may 
involve other mechanisms. 
The n-3 long-chain polyunsaturated fatty acid (LC-PUFA), EPA is the substrate for 3-
series eicosanoids, which plays a role in vasodilation, with less platelet aggregation, and less 
inflammation than 2-series eicosanoids, which may lower the risk of CVD (3)
 
(4).  On the other 
hand, the omega-6 long chain polyunsaturated fatty acid (n-6 LC-PUFA), arachidonic acid 
(ARA, 20:5n-6), is the substrate for pro-thrombotic and inflammatory 2-series eicosanoids.  Pro-
inflammation and increased thrombosis increases the risk of CVD.  EPA and ARA compete for 
the cyclooxygenase 2 (COX 2) enzyme to form their respective eicosanoids (4).  This has 
important implications because decreased ARA reduces synthesis of pro-thrombotic and 
inflammatory 2-series eicosanoids by COX 2.  Male Long Evans rats which received total 
parenteral nutrition fortified with fish oil (40% of total calories), rich in n-3 LC-PUFAs, had 
decreased 2-series platelet aggregating, thromboxane B2 (TXB2) and pro-inflammatory, 
prostaglandin F1α (5).  Most rodent feeding studies of n-3 PUFAs have used male rats (2) (6-12).  
Yet, gender differences in the metabolism of n-3 PUFAs has been reported (13).   Therefore, our 
study used female rats to further our understanding of n-3 PUFA metabolism.   
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Dietary fatty acids also play a role in lipogenesis and lipolysis.  Studies have shown that 
n-3 PUFAs decreased lipogenesis and increased lipolysis (2,6,8,9,14-18).  Enhancing lipogenesis 
promotes adiposity and in turn, obesity, which is a risk factor for CVD.  Additionally, 
lipogenesis can affect circulating serum lipids and lipoproteins, which are also risk factors for 
CVD.  The sterol regulatory element binding protein -1c (SREBP-1c) is a transcriptional 
regulator of various lipogenic genes including fatty acid synthase (FAS) and stearoyl Coenzyme-
A desaturase 1(SCD-1).  The multi-enzyme complex, FAS, adds two carbons to malonyl-CoA 
through a series of reactions that result in the synthesis of the main lipogenesis product, palmitic 
acid (16:0).  Further down the lipogenesis pathway, the rate limiting enzyme SCD-1 regulates the 
synthesis of saturated fatty acids (SFA) into monounsaturated fatty acids (MUFAs) (19).   In 
turn, MUFAs regulate synthesis of TGs and cholesterol (CHL) (20).  In a study by Flachs et al. 
(15), mice fed a diet high in EPA and DHA showed down-regulated gene expression of SCD-1 
in epididymal and subcutaneous fat; however, the study did not measure serum TG and CHL. 
 Increased n-3 PUFA consumption is recommended due to reports of decreased CVD risk 
and various other health benefits.  This has led to the availability of numerous n-3 PUFA 
sources.  The n-3 PUFAs include alpha-linolenic acid (ALA), EPA, and DHA.  ALA is an 
essential fatty acid in mammals and must be obtained through the diet.  One of the richest 
sources of ALA is flaxseed oil (FO) (21).  ALA can be converted into n-3 LC-PUFAs, EPA and 
DHA.  However, conversion to these n-3 LC-PUFAs is inefficient.  Approximately 5% of ALA 
is converted to EPA and <0.5% is converted to DHA (22).  Due to low conversion rate of ALA 
to EPA and DHA, intake of pre-formed n-3 LC-PUFAs in the diet is recommended.  Many 
marine sources are rich in n-3 LC-PUFAs.  Menhaden oil (MO) is high in total n-3 PUFAs.  
Salmon oil (SO) is a rich source of EPA, and tuna oil (TO) is a rich source of DHA (23).  Fatty 
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acids in fish oils such as SO, TO, and MO are in TG form; whereas, krill oil (KO) is in the TG 
and phospholipid (PL) form (24).  This difference has been suggested to affect bioavailability 
(25).  Increased EPA and DHA in plasma lipids depend on the bioavailability of pre-formed LC-
PUFAs from fish oil or concentrates (26).  Our laboratory previously showed that feeding 
different sources of n-3 fatty acids affected n-3 LC-PUFAs and n-6 LC-PUFAs composition in 
liver and gonadal adipose tissues (23).  Therefore, this thesis investigated the effect of feeding 
growing female rats different n-3 PUFA sources on the regulation of lipogenic and lipolytic gene 
expression and lipid metabolism in liver and adipose tissues. 
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2.0 Study Objectives 
2.1 Hypothesis: Consumption of different sources of n-3 PUFAs exert health benefits by 
decreasing lipogenic gene expression and increasing lipolytic gene expression.  In turn, n-
3 PUFAs decrease serum lipids and lipoproteins.  Additionally, increased tissue n-3 
PUFA content reduces inflammation by decreasing 2-series eicosanoid synthesis. 
2.2 Study Objectives 
Objective 1: To determine the effect of feeding growing female rats different sources of 
n-3 PUFAs on expression of genes regulating lipogenesis and lipolysis. 
Objective 2: To determine the effect of feeding growing female rats different sources of 
n-3 PUFAs on serum lipids and lipoproteins. 
Objective 3: To determine the effect of feeding growing female rats different sources of 
n-3 PUFAs on inflammation. 
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3.0 Literature Review 
3.1 Omega-3 and Omega-6 Polyunsaturated Fatty Acids 
Mammals lack the delta-12 and delta-15 desaturase enzymes, subsequently two fatty 
acids, the omega-6 polyunsaturated fatty acid, LA (18:2n-6) and the omega-3 polyunsaturated 
fatty acid, ALA (18:3n-3) are essential fatty acids and therefore, must be obtained through the 
diet (4).  The n-6 PUFAs are the main fatty acids found in vegetable oils. The fatty acid 
composition of corn oil (CO) is comprised of 61.1% LA (12).  Flaxseed oil is richer in ALA than 
other commonly consumed n-3 PUFA sources, such as walnuts and soybean oils (27).  After 
consumption, LA can be synthesized into the n-6 LC-PUFA, ARA (20:4n-6) and ALA can be 
synthesized into the n-3 LC-PUFAs, EPA (20:5n-3) and DHA (22:6n-3) (4).  The synthesis of 
ARA from LA utilizes the same enzymes as the synthesis of EPA and DHA from ALA.  
Therefore, LA and ALA compete for the same enzymes.    
As shown in Figure 1, the initial and rate limiting enzyme in the pathway is delta-6 
desaturase.  ALA has greater affinity for the delta-6 desaturase enzyme compared to LA (4).   
Consumed in equal amounts, this favors synthesis of n-3 PUFAs over n-6 PUFAs.  Therefore, 
consuming ALA increases tissue EPA and DHA.  However, conversion of ALA to EPA and 
DHA is low due to oxidation rather than tissue storage of ALA (26).  Females have been 
suggested to have lower oxidation rates of ALA (13) and therefore, more efficient conversion of 
ALA to n-3 LC-PUFAs.   
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Figure 1: Synthesis of n-3 and n-6 PUFAs  
 
The conversion rate of ALA to EPA and DHA is about 5% and <0.5%, respectively (22).  
This has led to suggestions to consume foods rich in pre-formed EPA and DHA, such as fish oil.  
In a rodent study, male spontaneously hypertensive rats provided a combination of EPA and 
DHA in fish oil showed reduced plasma TGs and total CHL, which are CVD risk factors, 
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compared to CO-fed rats (12).  However, studies have reported inconsistent results regarding n-3 
PUFAs’ effects on serum lipids and lipoproteins.  Intake of ALA (1,356mg/100g diet) in male 
Wistar rats did not significantly decrease serum TG and CHL levels, suggesting ALA may be 
diverted to other metabolic pathways (28).  Therefore, other mechanisms such as lipogenesis and 
lipolysis may be involved.  
3.2 Omega-3 Polyunsaturated Fatty Acids and Lipogenesis 
As reviewed by Lodhi et al.(29), de novo synthesis of lipids mainly occurs in the liver 
and adipose tissues.  As shown in Figure 2, lipogenesis begins with the synthesis of citrate from 
acetyl CoA and oxaloacetate.  In the cytosol, citrate lyase, converts citrate to acetyl CoA.  The 
committed step of fatty acid synthesis is the synthesis of malonyl CoA from acetyl CoA which is 
regulated by acetyl CoA carboxylase (ACC).  The multi-enzyme complex, FAS adds two 
carbons to malonyl-CoA through a series of reactions that result in the synthesis of the 16 carbon 
fatty acid, palmitic acid.  Male Wistar rats (age 6 weeks old) fed a high (62% energy) fat 
“cafeteria” diet ad libitum for 5 weeks showed up-regulated (P<0.001) FAS gene expression in 
the liver (9).  However, supplementation of EPA ethyl ester (1g/kg body weight) attenuated 
(P<0.05) increased FAS gene expression in hepatic tissue (9).  Male Sprague-Dawley rats fed a 
high (58%) glucose diet containing 10% menhaden oil rich in EPA and DHA, for 5 days resulted 
in a 97% decrease in hepatic mRNA expression of FAS as measured by dot analysis, compared 
to rats fed the high glucose diet containing 10% triolein, a TG containing monounsaturated fatty 
acids (MUFAs), oleic acid (18:1n-9) (6).  Raclot et al. (8) fed male Wistar rats (age 50 days old) 
diets with fat sources consisting of MUFAs, EPA ethyl ester, DHA ethyl ester, both EPA and 
DHA ethyl esters, or fish oil.  FAS gene expression normalized to the fish oil group was 
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decreased (P<0.05) in rats fed DHA ethyl ester and DHA and EPA ethyl esters groups compared 
to the MUFA group.   
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Figure 2: Lipogenesis Pathway 
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Male Sprague-Dawley rats fed a high fat diet (35% kcal lard) supplemented with 2.5% krill oil, 
which contains n-3 PUFAs in phospholipid form, resulted in a 60% inhibition of FAS activity in 
the liver cytosol compared to rats fed a high (35% kcal) fat diet without krill oil supplementation 
and rats fed a low (6% kcal) fat diet (14).       
 The end product of FAS is palmitic acid (16:0).  Longer-chain fatty acids can be 
synthesized by addition of 2 carbons by elongase enzymes.  Unsaturated fatty acids can be 
synthesized by desaturase enzymes which add double bonds.  The desaturase enzyme, SCD-1 
synthesizes the MUFAs, palmitoleic acid (16:1n-7) and oleic acid (18:1n-9).  SREBP-1c is a 
transcriptional regulator of various lipogenic genes including SCD-1(Figure 2).  Lu et al. (2) 
found that obese male rats (age 8 weeks old) fed a hypercholesterolemic diet supplemented with 
fish oil derived DHA/EPA decreased SREBP-1c mRNA expression in hepatic tissue (P<0.01) 
and adipose tissue (P<0.05) compared to rats fed a hypercholesterolemic diet without DHA/EPA 
supplementation.  Since the transcriptional factor SREBP-1c regulates SCD-1, which synthesizes 
palmitoleic and oleic acid which are precursors of TG and CHL (Figure 2), down-regulation of 
genes regulating lipogenesis may reduce risk of CVD and fatty liver. 
 Muhlhausler et al. (18) examined multiple genes related to lipid metabolism in the 
adipose tissue.  Growing (age 6 weeks) female Dark Agouti rats were fed 100% macadamia oil 
diet (containing 0.016% ALA and 0.27% LA) for 3 weeks to ensure comparable baseline fatty 
acid.  After 3 weeks, the growing rats were fed the experimental diets consisting of a basal diet 
with 5% (v/v) fat with varying amounts of ALA (0.095%, 0.19%, 0.38%, 0.76%, 1.00%, 2.05%, 
4.1%, and 6.3% total energy) ad libitum for 3 weeks.  In omental adipose tissue, mRNA 
expression of the transcription factor SREBP-1c and the enzymes, SCD-1 and FAS resulted in a 
dose-dependent increase until a maximal dose of 0.38% ALA.  In retroperitoneal adipose tissue, 
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dietary ALA showed a dose-dependent decrease (P<0.05) in SREBP-1c expression.  FAS 
expression was lowest (P<0.001) when ALA in the diet was ≥4.1% total energy (18).  Male 
C57BL/6J mice fed a semi-synthetic high fat (20% total energy) diet consisting of 56% total 
lipid as flaxseed oil rich in ALA and 44% total lipid as EPA/DHA supplementation (EPAX 
1050TG) significantly reduced SCD-1 gene expression in epididymal adipose tissue compared to 
the mice fed semi-synthetic high fat diet with 100% total lipid as flaxseed oil (15).  Male 
C57BL/6J mice fed a high fat (35.2% total energy) diet with 81% rapeseed oil rich in ALA, 4% 
sunflower oil, and 15% EPA/DHA (EPAX 1050TG) resulted in decreased SCD-1 expression in 
the epididymal fat adipocytes compared to mice fed a high fat diet with 95% rapeseed oil and 5% 
sunflower oil (15).  The studies indicated that n-3 PUFAs decrease lipogenic gene expression, 
with the n-3 LC-PUFAs, EPA and DHA, showing greater effectiveness.  In contrast, weaned 
male Hooded-Wistar rats were fed diets with equal amounts of LA, but different amounts of 
ALA (0.2%, 0.5%, 1%, 1.9%, and 2.9%) for 3 weeks showed no significant differences in 
hepatic SREBP-1c expression (30).  Additionally, SREBP-1c did not significantly differ when 
fed a high (6.6% weight) PUFA diet consisting of 5% by weight of the total diet as soybean oil, a 
rich source of ALA and LA, compared to a low (0.4%) PUFA consisting of 5% macadamia oil, 
rich in palmitoleic acid (30).  Tu et al. (30) reported that n-3 PUFAs did not alter lipogenic gene 
expression in hepatic tissue.  However, other studies reported that n-3 PUFAs altered lipogenic 
gene expression in adipose tissue (15,18).  Therefore, our study examined lipogenic gene 
expression in both the liver and adipose tissue.  Since the body regulates lipid stores through a 
balance of lipogenesis and lipolysis, the next section discusses n-3 PUFAs’ effects on lipolysis.     
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3.3 Omega-3 Polyunsaturated Fatty Acids and Lipolysis 
 As reviewed in Kraemer et al. (31), hormones such as glucagon, catecholamines, and 
corticotropin stimulate the enzyme, hormone sensitive lipase (HSL) (11).  In turn, HSL releases 
fatty acids stored in the adipose tissue.  Male Wistar rats (age 6 weeks old) fed a high fat diet 
(62% total energy) decreased (P<0.001) HSL mRNA levels in retroperitoneal adipose tissue 
compared to rats fed a standard pelleted diet (6% lipid as total energy).  Rats fed a high fat diet 
supplemented with EPA ethyl ester (1g/kg) for 35 days attenuated the decreased HSL mRNA 
levels observed in rats fed a high fat diet (16).  Male Wistar rats (age 50 days old) fed high-fat 
(200g/kg diet) diets supplemented with DHA ethyl esters or a mixture of EPA and DHA ethyl 
esters for 4 weeks decreased (P<0.05) HSL mRNA levels, when normalized to rats fed a high-fat 
diet with fish oil, in retroperitoneal adipose tissue compared to rats fed high-fat diets 
supplemented with EPA ethyl esters or a mixture of lard and olive oil containing no n-3 PUFAs 
(8).  The results indicated that lipolysis was down-regulated.  In a human double-blind crossover 
study, men with type 2 diabetes were provided either a fish oil or sunflower oil supplement for 2 
months.  Participants had higher HSL mRNA levels after being provided the fish oil supplement 
compared to when provided sunflower oil supplementation (17).  The higher HSL mRNA levels 
in type 2 diabetic men with fish oil supplementation coincided with significantly lower 
circulating TG levels (17), suggesting lower risk of CVD.   
HSL is regulated by the transcription factors PPARα (32) and PPARγ (33).  PPARγ is a 
transcription factor that regulates genes involved in the release and uptake of fatty acids from the 
adipose tissue.   Muhlhausler et al. (18) found that feeding female Dark Agouti rats varying 
amounts of ALA (0.095%, 0.19%, 0.38%, 0.76%, 1.00%, 2.05%, 4.1%, and 6.3% total energy) 
had no significant effect on PPARγ gene expression in omental adipose tissue.   
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The transcription factor, PPARα, regulates the expression of genes involved in hepatic 
mitochondrial and peroxisome fatty acid oxidation.  Tu et al. (30) fed weaned male Hooded-
Wistar rats different doses (0.2 to 2.9%) of ALA in the diet for 3 weeks and reported no 
significant differences in hepatic PPARα gene expression.  Similarly, in a feeding study of a high 
(6.6%) PUFA diet with 5% by weight of total diet as soybean oil or a low (0.4%) PUFA diet 
with 5% by weight of total diet as macadamia oil, showed no significant differences in PPARα 
expression (30).  The results indicated that the amount of PUFAs did not affect gene expression 
of the lipolytic transcription factor, PPARα.  On the other hand, the type of fatty acid affected 
HSL and PPARα expression.  PUFAs, but not SFAs, bind directly to PPARα, which can induce 
β-oxidation (34).  Perez-Echarri et al. (9) fed male rats a standard rat pellet diet or a high (62% 
energy) fat “cafeteria” diet supplemented with EPA ethyl ester (1g/kg body weight) found EPA 
ethyl ester supplementation decreased (P<0.01) PPARα mRNA expression in hepatic tissue.   
EPA and DHA can be in TG and PL forms.  To our knowledge, no studies have been 
conducted to compare the effects of n-3 PUFAs in different lipid forms on HSL, PPARα, or 
PPARγ gene expression.  Therefore, our study examined the effects of feeding n-3 PUFA 
sources with different types and structural forms of n-3 LC-PUFAs.  Since altering lipogenesis 
and lipolysis balance can affect circulating lipids, the next section reviews the effects of dietary 
lipids on serum lipids and lipoproteins.   
 
3.4 Omega-3 Polyunsaturated Fatty Acids and Serum Lipids and Lipoproteins  
 
 As reviewed by Magkos (35), the liver packages de novo synthesized TGs into very low 
density lipoproteins (VLDL).  VLDLs are hydrolyzed by lipoprotein lipase (LPL), which 
releases TG to form VLDL remnants and intermediate-density lipoproteins (IDL), which in turn 
are taken up by the liver to be converted into low density lipoproteins (LDL-C) that transport 
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CHL to the tissues.  High density lipoproteins (HDL-C) transport excess cholesterol from the 
tissues back to the liver (36).   
Zhu et al. (37) fed adult male rats a high (0.5ml/100g body weight) fat diet (78.8% feed, 
1% cholesterol, 10% yolk powder, 10% lard, and 0.2% cholate) supplemented with various doses 
of krill oil (16.65, 33.3, 99.9,199.8g/L) for 4 weeks.  All doses of krill oil decreased (P<0.05) 
total serum cholesterol, triglycerides, and LDL-C compared to baseline levels (37).  High fat 
diets supplemented with krill oil doses of 16.65g/L and 33.3g/L dosage decreased (P<0.05) 
serum TGs compared to the high fat diet (37).  High fat diets supplemented with all doses of krill 
oil decreased (P<0.05) total cholesterol and LDL-C levels (37).   High (99.9g/L and 199.8g/L) 
doses of krill oil also significantly (P<0.05) increased HDL-C levels (37).  Our study compared 
the effects of various marine sources of n-3 LC-PUFAs, including krill oil, on serum lipids and 
lipoproteins.      
Morgado et al. (11) compared the effects of fish oil rich in n-3 PUFAs, sunflower oil rich 
in n-6 PUFAs, olive oil rich in omega-9 (n-9) PUFAs, and coconut oil rich in saturated fatty 
acids (SFAs) on serum lipid profiles in growing (age 8-10 weeks old) male Wistar rats.  The 
diets were isocaloric with 15% of the total kcal as lipids consisting of 5% from sunflower oil to 
provide essential fatty acids and 10% from the experimental oil source.  Diets were fed ad 
libitum.  Plasma total CHL and TG concentrations were significantly decreased in rats fed fish 
oil compared to sunflower oil, olive oil, and coconut oil.  In addition, VLDL and HDL-C levels 
were significantly decreased in rats fed fish oil compared to the sunflower oil, olive oil, and 
coconut oil groups.  Decreased HDL-C coincides with decreased total CHL because rodents 
mainly transport cholesterol in the HDL-C fraction (36).  However, it was not specified whether 
the serum lipids were fasting values and duration of the feeding study was not provided. 
15 
 
 Another study used obese male rats fed either hypercholesterolemic diet or 
hypercholesterolemic diet supplemented with 5% of total fat (15% w/w) as EPA/DHA derived 
from fish oil for 16 weeks(2).  Fasting serum CHL and TG were decreased (P<0.05) in rats fed 
the EPA/DHA supplemented diet.  However, there were no significant effects on HDL-C and 
LDL-C fractions.  Based on the study results, supplementation with n-3 LC-PUFAs decreased 
serum lipids, but not serum lipoproteins (11) (2).  Therefore, n-3 PUFAs may reduce CVD risk 
through other mechanisms such as: platelet aggregation, vasoconstriction, and inflammation.    
 
3.5 Omega-3 Polyunsaturated Fatty Acids and Eicosanoid Synthesis 
 The n-6 PUFA, ARA, is the substrate for 2-series eicosanoids.  The eicosanoids consist 
of prostaglandins and thromboxanes (38).  Prostaglandins regulate inflammation.  Thromboxanes 
regulate platelet aggregation and contraction of vascular smooth muscle (39).  EPA competes 
with ARA for the eicosanoid synthesizing enzyme, cyclooxygenase 2 (COX 2) (Figure 3).  EPA 
is the substrate for 3-series eicosanoids.  The 3-series eicosanoids have less potent inflammation, 
and platelet aggregation and vasoconstriction compared to the 2-series eicosanoids (Figure 3).   
Therefore, increased n-3 LC-PUFAs can reduce CVD risk by altering eicosanoids.   
Yeh et al. (5) utilized total parenteral nutrition (TPN) to analyze the short-term effect of 
n-3 PUFA intake on prostaglandin synthesis.  Male Long Evans rats were fed standard rat chow, 
or isonitrogenous TPN containing either safflower oil rich in LA or fish oil rich in EPA, as a fat 
emulsion for 7 days.  The fish oil TPN group had the lowest (P<0.05) plasma thromboxane B2 
(TXB2) concentrations among the groups (5).  However, the type of fish oil utilized in this study 
was not specifically stated and DHA was not measured (5).  Another study examined safflower 
oil, fish oil, and ALA provided as a TG mixture of 97% ALA (40).  Weanling male Sprague-
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Dawley rats were fed isocaloric basal diets containing (10% by weight) fat as ALA, refined 
menhaden oil, or safflower oil for 12 weeks.  Incubation of lung homogenates of rats fed ALA 
and menhaden oil decreased (P<0.05) TXB2 concentrations compared to rats fed safflower oil 
rich in LA (40).  The results indicated that supplementation of n-3 PUFAs decreased 2-series 
eicosanoids.  
 Sohal et al. (41) studied the effects of n-3 PUFAs on PGE2.  Male Sprague-Dawley rats 
were fed a diet high in n-3 PUFAs (19% total fat) or a diet low in n-3 PUFAs (1.4% total fat) 
from fish oil.  At week 3, diabetes was induced in half of the rats by a single tail-vein injection of 
streptozotocin (50 mg/kg body wt) in acetate buffer.  The high n-3 PUFA diet decreased 
(P<0.0001) synthesis of PGE2 by approximately 75%.  The results indicated that high (19% total 
fat) amounts of n-3 PUFAs competitively inhibited synthesis of 2-series prostaglandins.    
 Male Fischer rats provided azoxymethane injections to initiate colon cancer were fed a 
purified diet with either 15% flaxseed meal rich in ALA or 15% corn meal rich in LA ad libitum 
(42).  The rats fed corn meal had higher (P<0.05) COX 2 levels in colon microsomes (42).  Rats 
with chronic renal failure, providing 7:1 EPA:DHA supplementation attenuated the up-regulated 
COX 2 protein abundance in renal tissue associated with surgically induced chronic renal failure 
(43).  Sankaran et al. (44) fed weanling Han:SPRD-cy rats, a genetic model of polycystic kidney 
disease, a  high fat (20g/100g diet) or low fat (5g/100g diet) diet containing cottonseed oil rich in 
LA, menhaden oil rich in EPA and DHA, or soybean oil (4:1g/g) rich in ALA and LA for 6 
weeks.  Han:SPRD-cy rats fed the high menhaden oil diets had approximately five times more 
COX 2 protein levels and low menhaden oil diets had 1.2 times more COX 2 protein levels in the 
kidneys compared to rats fed the high or low fat cottonseed diets (44).  On the other hand, 
weanling male Han:SPRD-cy rats provided 7% corn oil rich in LA or 7% flaxseed/corn oil 
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containing flaxseed/corn oil (4:1, g/g) rich in ALA diets for 12 weeks showed no significant 
differences in renal COX 2 protein or gene expression (44).  
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Figure 3: Eicosanoid Synthesis Pathway 
 
The study results indicated that n-3 LC-PUFAs, EPA and DHA, but not ALA decreased COX 2.  
COX 2 protein and gene expression altered inflammation which plays a role in disease 
progression.  The literature showed beneficial effects of n-3 PUFA supplementation in disease 
states.  However, the general public is currently being advised to consume n-3 PUFAs as a 
preventative measure against disease risk.  Therefore, our study analyzed the effects of n-3 
PUFA supplementation using non-diseased animals.  
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3.6 Omega-3 Polyunsaturated Fatty Acids and Inflammation 
Inflammation can also be regulated by mechanisms other than altering eicosanoids.  
Nuclear Factor Kappa B (NFKB) is a key transcription factor that can mediate activation of 
inflammation.  Inhibitor Kappa B Alpha (IKBα) regulates cytoplasmic retention of NFKB by 
inhibiting DNA binding by NFKB, recruitment and inhibition of protein kinase A (PKA) in the 
IKB/NFKB complex, and removal of NFKB from the nucleus (45).  The human pro-monocytic 
cell line U937 treated with n-6 PUFA, ARA (45mM) increased NFKB binding/activation.  On 
the other hand, treatment with n-3 PUFA, EPA (45mM) had no significant effect on nuclear 
translocation (46).  Nuclear translocation of the p65 NFKB subunit is key for NFKB activity.  
Western blots of nuclear proteins from DHA-pretreated human saphenous vein endothelial cells 
(HSVEC) cells showed significantly less p65 nuclear translocation into nuclei, but not total 
cellular p65 compared to non-treated HSVEC cells (47).   
EPA has been suggested to prevent IKBα degradation and NFKB translocation by 
preventing the phosphorylation of IKBα (48).  NFKB is kept in an inactive form by the 
inhibitory subunit IKB in most cell types (48). Phosphorylation of IKB by IKKs leads to its 
ubiquitination and subsequent degradation resulting in the translocation and activation of NFKB 
(48).   
Lipopolysaccharide (LPS) stimulation decreased the levels of IKBα and increased the 
levels of p-IKBα (48).  EPA pre-treatment significantly suppressed the levels of LPS-induced p-
IKBα by 40% at 15 min and by 50% at 30 min (48).  Measurement of band densities from a 
Western Blot indicated that EPA pre-treatment of THP-1 cells inhibited LPS-induced decrease in 
IKBα by 18% at 30 min (48).  However, the IKBα levels represented the total amount of pre-
existed and newly synthesized IKBα since IKBα gene expression is up-regulated by the 
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activation of NFKB.  A decrease in NFKB activation by EPA may result in a slow regeneration 
of IKBα that reduced the difference in IKBα levels between EPA treated and non-treated cells 
(48).  Proximal tubular epithelial cells treated with EPA prevented LPS-induced NFKB 
activation and pre-treatment with IKBα siRNA abolished the effect of EPA.  The results 
indicated that EPA inhibited NFKB activation by regulating IKBα (49).  The n-3 LC-PUFAs, 
EPA and DHA, decreased inflammation; however, specific fatty acid and doses may affect this 
alteration.  Our study examined the effect of feeding healthy animals different n-3 LC-PUFA 
sources on IKBα gene expression.   
 
3.7 Summary 
Changing dietary n-3 PUFA intake may be a preventive strategy for reducing risk of 
CVD as well as other diseases.  The effects of n-3 PUFAs on lipogenesis and lipolysis can affect 
tissue fatty acid composition and circulating lipids and subsequently, health status and disease 
risk.  Studies examining the effects of n-3 LC-PUFA intake on serum lipids and lipoproteins 
have produced inconsistent results (2,11,37).  Instead, n-3 LC-PUFAs may decrease CVD risk by 
influencing inflammation such as: reducing synthesis of 2-series eicosanoids involved in the 
regulation of inflammation, platelet aggregation, and vasoconstriction.  Studies have reported 
that gene regulation of lipolysis, lipogenesis, serum lipids and lipoproteins, and inflammation 
depended on the type of n-3 LC-PUFAs supplemented.  Therefore, our study investigated the 
effects of feeding popular and novel sources of n-3 PUFAs. 
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4.0 Materials and Methods 
4.1 Diets 
Experimental diets fed to animals were formulated to match the standard purified 
American Institute of Nutrition-93G (AIN-93 G) diet (Appendix 1).  The AIN-93G meets the 
nutritional requirements for growing rats as defined by the National Research Council (1996).  
Modifications of the AIN-93G diet consisted of replacing 7% lipids with 12% lipid by weight.  
The high fat diet (~27% kcals) was used to reflect the high fat intake typical of the Western diet 
(~33% kcals).   The dietary oils consisted of either: 1) corn oil (CO), 2) flaxseed oil (FO), 3) krill 
oil (KO), 4) menhaden oil (MO), 5) salmon oil (SO) or 6) tuna oil (TO).  All diets were adjusted 
to be isocaloric. 
Table 1 summarizes the characteristics of the dietary oils.  The lipid sources were 
selected on the basis that CO has a high n-6:n-3 PUFA ratio which is prevalent in the Western 
diet.  KO had the highest total n-3 PUFA content followed by FO.  Of the oil sources, FO had the 
highest ALA content.  Of the fish oils, SO had the highest EPA content and in turn, the highest 
EPA:DHA ratio.  Of the fish oils, TO had the highest DHA content and in turn, the lowest 
EPA:DHA ratio.  Dietary n-3 PUFAs were in TG form in FO and fish oil sources.  In KO, n-3 
PUFAs were equally distributed in TG and PL (25).   To meet the National Research Council 
(1995) nutrient requirements for the essential n-6 PUFA, LA, it was necessary to add CO (2% 
lipids by wt) to the KO and MO (10% lipids by wt) diets (Appendix 1).  The CO, FO, MO, SO, 
and TO were provided by J. Edwards International Inc (Quincy, MA).  KO was obtained from 
Enzymotec Ltd. (Morristown, NJ). 
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4.2 Animal Feeding Study 
All animal procedures were approved by the Animal Care and Use Committee at West 
Virginia University and were conducted in accordance with the guidelines set forth by the 
National Research Council Guide for the Care and Use of Laboratory Animals (1996).  Growing 
(28 d) female Sprague-Dawley rats (n=60) were purchased from Taconic Farms (Rockville, 
MD).  Upon arrival at the West Virginia University animal care facility, rats were individually 
caged in metabolic cages to determine food intake.  Rats were kept housed in rooms maintained 
at 21°C with a 12 h light/dark cycle throughout the 8 week feeding study.   Following 7 d 
acclimation, rats (n=10/group) were randomly assigned to experimental diets consisting of CO, 
FO, KO, MO, SO or TO.  Diets were stored at -20°C until fed.  
All rats were provided 15 ± 0.75 g diet/d of their assigned diet to prevent variability in 
food intake.  This amount was based on the average amount of food consumed daily by growing 
female Sprague-Dawley rats (50).  Food intake was measured and replaced with fresh diet daily.  
Water consumption and body weights were measured weekly throughout the 8 week feeding 
study.  At the end of the 8 week feeding study, rats were fasted overnight, and then euthanized 
by CO2 inhalation.   
4.3 Determination of Gene Expression  
Shown in Table 2 is a list of lipogenesis and lipolysis genes measured in the present study 
and their functions. 
Gene Expression  
Liver and gonadal adipose tissues were dissected then weighed.  Retroperitoneal adipose 
tissue was not analyzed because there was not enough mRNA to properly amplify on qPCR.  
Tissues were immediately frozen in liquid nitrogen and stored at -80°C until analyzed.  Total 
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RNA in the liver was isolated using the mirVana™ Isolation Kit (Ambion Inc, Foster City, CA) 
according to the manufacturer's instructions for total RNA isolation.  To isolate RNA in the 
adipose tissue, the RNeasy Lipid Tissue Mini Kit (Qiagen) was used.  TURBO DNase kit 
(Ambion/Life Technologies) was then used on the RNA samples.  First strand complementary 
DNA (cDNA) was synthesized using the SuperScript III First-Strand Synthesis System 
(Invitrogen, Carlsbad, CA).  Gene expression of transcription factors and enzymes was 
determined by qPCR.  The housekeeping gene GAPDH was used as a reference. The primer 
sequences for GAPDH are (forward) 5’ - TCA AGA AGG TGG TGA AGC AG - 3’ and 
(reverse) 5’ - CCT CAG TGT AGC CCA GGA TG - 3’.  Primer efficiencies were determined 
using LinRegPCR software.  Gene expression results were analyzed using Relative Expression 
Software Tool (REST) 2009 (51).     
Lipogenic Gene Expression 
SREBP-1c is a key transcription factor in fatty acid and cholesterol synthesis.  The 
primer sequences for SREBP-1c are (forward) 5’ GCC TGC TTG GCT CTT CTC T 3’ and 
(reverse) 5’ GCT TGT TTG CGA TGT CTC C 3’.  FAS is the enzyme that regulates synthesis of 
palmitic acid.  The primer sequences for FAS are (forward) 5’- GCT GCT ACA AAC AGG 
ACC ATC-3’ and (reverse) 5’- TCC ACT GAC TCT TCA CAG ACC A-3’.  SCD-1 is the key 
enzyme in the synthesis of MUFAs.  The primer sequences for SCD-1 are (forward) 5’-TTC 
GCC ACT GAC TTG CTA TG-3’ and (reverse) 5’- CAG GAG GTT CTT GGG ATG ATT -3’. 
Lipolysis Gene Expression 
HSL is a key enzyme in the mobilization of fatty acids from adipose tissue.  The primer 
sequences for HSL are (forward) 5’- TCT TCT TTG AGG GCG ATG AG -3’and (reverse) 5’- 
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GCA GCC TTT ATG TAG CGT GA -3’.  PPARα is a transcription factor regulating genes 
involved in lipolysis.  The primer sequences for PPARα are (forward) 5’- ATG AAC AAA GAC 
GGG ATG CT -3’ and (reverse) 5’- AGG AAC TCT CGG GTG ATG AA -3’.  The transcription 
factor PPARγ plays a variety of roles in the adipose, including regulation of genes involved in 
the release and uptake of fatty acids from adipose tissue.  The primer sequences for PPARγ are 
(forward) 5’- GGA AAG ACA ACA GAC AAA TCA CC-3’and (reverse) 5’- CGA AAC TGG 
CAC CCT TGA -3’.   
Inflammation Gene Expression 
The n-3 PUFAs have been suggested to reduce inflammation in the body (4).  Therefore, 
our study analyzed IKBα and COX 2.  IKBα alters inflammation through the NFKB pathway and 
COX 2 affects inflammation through the eicosanoid synthesis pathway.  The primer sequences 
for COX 2 are (forward) 5’ TCA ATG CAA AAG GTA TCA GTG G 3’ and (reverse) 5’ ACC 
GTG AGC TGG AAG ACA TT -3’.   The primer sequences for IKBα are (forward) 5’- CTG 
GTC TCG CTC CTG TTG A -3’ and (reverse) 5’- GCC CTG GTA GGT TAC TCT GTT G -3’.   
4.4 Determination of Fatty Acid Composition 
Lipid Extraction 
At the end of the 8 week feeding study, rats were euthanized by CO2 inhalation.  Liver 
and gonadal adipose tissues were dissected and then weighed.  Tissues were immediately frozen 
in liquid nitrogen and stored at -80°C until analyzed.  Lipids were extracted according to Bligh 
and Dyer (52).  Briefly, aliquots of liver (0.5 g) or adipose tissue (0.025 g) samples were added 
to Tris/EDTA buffer (pH 7.4) and 48 µl nonadecenoic (19:1) added as an internal standard.  
Chloroform:methanol:acetic acid (2:1:0.15 v/v/v) solution was added and samples were 
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centrifuged at 900 g for 10 min at 10°C.  The collected chloroform layer was filtered through 1-
phase separation filters.  The centrifugation and filtration steps were repeated and the extracted 
lipid was dried under nitrogen gas.   
Fatty Acid Methylation 
The extracted lipid samples were transmethylated according to Fritsche and Johnston 
(53).  Briefly, fatty acids were methylated by adding 4% sulfuric acid in anhydrous methanol to 
the extracted lipid samples followed by incubation in a 90°C water bath for 60 min.  Samples 
were cooled to room temperature and 3 mL of deionized distilled water was added.  Chloroform 
was added to the methylated samples and centrifuged at 900 g for 10 min at 10°C.  The collected 
chloroform layer was filtered through anhydrous sodium sulfate to remove remaining water.  
Samples were dried under nitrogen gas.  Dried samples were diluted in iso-octane to a 
concentration of 5 mg FAME (fatty acid methyl esters)/mL iso-octane.   
FAME samples were analyzed by gas chromatography (CP-3800, Varian, Walnut Creek, 
CA) using an initial temperature of 140°C held for 5 min and then increased 1°C per min to a 
final temperature of 220°C.  Total separation time was 60 min.  A wall-coated open tubular fused 
silica capillary column (Varian Inc., Walnut Creek, CA) was used to separate FAMEs with CP-
Sil 88 as the stationary phase.  Nitrogen was used as the carrier gas.  Quantitative 37 Component 
FAME Sigma Mix (Supelco, Bellefonte, PA) was used as a standard to identify fatty acids.  The 
n-3 PUFAs, ALA, EPA, and DHA, and the n-6 PUFAs, LA and ARA were determined.  The 
FAS end product palmitic acid (16:0) and SCD-1 end products, palmitoleic (16:1n-7) and oleic 
acid (18:1n-9), and oleic acid precursor stearic acid (18:0) were quantified using peak area 
counts and retention time. 
4.5 Liver Triglyceride Content 
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Total liver triglyceride content was measured using a commercially available triglyceride 
colorimetric assay kit (Cayman Chemical, Ann Arbor, MI).  Briefly, 350-400 mg liver tissue was 
homogenized in standard diluent.  Samples were centrifuged, and the supernatant was collected 
and diluted 1:5 in standard diluent.  Absorbance was determined at 530 nm using a Spectramax 
Plus microplate reader (Molecular Devices, Sunnyvale, CA).  All samples were determined in 
duplicate and values were expressed as triglycerides (mg/dl). 
4.6 Serum Lipid and Lipoprotein Analysis 
Immediately following euthanization, the chest cavity was opened and the aorta was 
punctured to collect blood.  The collected blood was centrifuged at 1,500 g for 10 min at 4°C and 
the serum was collected and kept frozen at -80°C until analyzed.  Fasting serum cholesterol, TG, 
VLDL, LDL-C, and HDL-C were determined by lipid test rotor enzymatic colorimetric assays 
and measured using a Hemagen Analyst automated spectrophotometer (Hemagen Diagnostics 
Inc., Columbia, MD).   
4.7 Determination of 2-Series Eicosanoids      
TXB2 and PGE2 derived from ARA are short-lived molecules.  Therefore, the stable 
metabolites, 11-dehydro TXB2 and 13, 14-dihydro-15-keto PGE2, were measured.  Rats were 
individually housed in metabolic cages to collect urine.  Ascorbic acid (0.1%) was added to the 
urine collection tubes as a preservative and mineral oil (1 mL) to prevent evaporation.  Pooled 7 
d urine samples were collected during the final week of the 8 week feeding study.  Collected 
urine samples were centrifuged at 1,500 g for 10 min at 4
o
C.  Following centrifugation, urine 
samples were aliquoted into clean tubes.  Urinary 11-dehydro TXB2 and 13, 14-dihydro-15-keto 
PGE2 were determined using a commercially available enzyme immunoassay kits (Cayman 
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Chemical, Ann Arbor, MI).  Absorbance was determined at wavelength 405 nm using a 
Spectramax Plus microplate reader (Molecular Devices, Sunnyvale, CA). 
4.8 Statistical Analysis 
All results are expressed as mean ± SEM.  Data was analyzed by one-way analysis of 
variance (ANOVA) to determine the differences among the diet groups.  Post hoc multiple 
comparison tests were performed using Tukey’s (parametric) or Kruskal-Wallis (non-parametric) 
test with results considered significant at P< 0.05.  All statistical analyses were performed using 
Sigma Stat 3.1 (Abacus Concepts, Berkeley, CA).  Statistically significant differences in gene 
expression were analyzed by pairwise fixed reallocation randomization test as a statistical model 
in the relative expression software tool (REST) program developed for group-wise comparison 
and statistical analysis of relative expression results (51).
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5.0 Results 
5.1 Dietary Fatty Acid Content 
 Shown in Table 3, of the n-6 PUFAs, CO and FO diets had increased (P<0.001) dietary 
LA content compared to KO, MO, SO, and TO diets.  Of the n-3 PUFAs, the FO diet had the 
highest (P<0.001) dietary ALA content.  The KO diet had the highest (P<0.05) dietary EPA 
content compared to all diets, except SO.  SO diet had increased (P<0.05) dietary EPA compared 
to the TO, FO, and CO diets.  DHA content in marine oils was higher than FO and CO diets.  
Of the MUFAs, the fish oil diets (MO, SO, TO) had higher (P<0.001) dietary palmitoleic 
acid (16:1n-7) content compared to the KO, FO, and CO diets.  The FO diet had higher dietary 
oleic acid (18:1n-9) content than the fish oil groups, MO (P=0.007), SO (P=0.036), and TO 
(P=0.034) diets.  Of the SFAs, there were no significant differences for palmitic acid (16:0) 
content in diets.  The FO diet had the highest (P<0.001) amount of stearic acid (18:0). 
5.2 Body and Organ Weights 
No significant differences were found in food intake, body weight gain or final body 
weight among the diet groups.  Rats fed SO, TO, or KO had heavier (P<0.001) liver weights 
compared to FO or CO-fed rats.  There were no significant differences in gonadal adipose tissue 
weights among the diet groups (Appendix 2).
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5.3 Liver and Gonadal Adipose Tissue Polyunsaturated Fatty Acids 
Liver Tissue 
Previously, Tou et al.(25) reported rats fed SO and TO diets had higher (P<0.001) total n-
3 PUFA deposition in the liver compared to the other diet groups.  Liver ALA content was 
highest (P<0.001) in rats fed the FO diet.  EPA liver content was highest (P<0.001) in rats fed 
the SO diet.  Liver DHA was highest (P<0.001) in rats fed SO and TO diets.  TO had the lowest 
(P<0.05) EPA:DHA ratio (Appendix 3).  Rats fed n-3 PUFAs had lower (P<0.001) liver LA 
deposition than CO-fed rats.  Rats fed marine oils had lower (P=0.01) liver LA deposition than 
FO-fed rats.  Liver ARA deposition was highest (P<0.01) in TO-fed rats.  Rats fed FO, KO, and 
MO had lower (P<0.001) liver ARA than SO, TO, or CO-fed rats (Appendix 3).  
Gonadal Adipose Tissue 
 Previously, Tou et al. (25) reported that rats fed FO diet had the highest (P<0.001) 
gonadal adipose tissue ALA deposition.  Rats fed KO diet had the highest (P<0.05) gonadal 
adipose tissue EPA content.  Rats fed MO had higher (P=0.007) gonadal adipose tissue EPA 
content compared to the FO and CO-fed rats.  Gonadal adipose tissue DHA was higher (P<0.05) 
in rats fed MO and TO compared to rats fed the SO, FO, and CO diets.  Gonadal adipose tissue 
DHA was higher (P<0.001) in the KO compared to the FO and CO diet groups.  Rats fed all n-3 
PUFA sources had lower (P<0.001) gonadal adipose LA content compared to the CO diet group.  
Rats fed TO had the highest (P<0.05) gonadal adipose ARA content (Appendix 4).   
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5.4 Liver and Gonadal Adipose Tissue Lipogenic Gene Expression  
Liver Tissue 
Hepatic SREBP-1c gene expression was down-regulated in the MO (P=0.007) compared 
to the CO diet group (Figure 4a).  FAS gene expression was down-regulated in the FO 
(P=0.010), MO (P=0.001), SO (P=0.001), and TO (P=0.006) diet groups compared to the CO 
group (Figure 4b).  In the liver, SCD-1 expression was down-regulated in the MO (P=0.008) 
and the TO (P=0.04) diet groups compared to the CO diet group (Figure 4c). 
Gonadal Adipose Tissue   
In the gonadal adipose tissue, there were no significant differences in gene expression for 
SREBP-1c, FAS, or SCD-1 for the n-3 PUFA diet groups compared to the CO diet group 
(Figures 5a-c).   
5.5 Liver and Gonadal Adipose Tissue Saturated and Monounsaturated Fatty Acids 
Liver Tissue  
Hepatic palmitic acid content was significantly higher in rats fed SO and TO diets 
compared to rats fed MO, FO, and CO diets (Figure 6a).  Hepatic stearic acid (18:0) content was 
increased (P<0.005) in rats fed TO diet compared to KO, MO, and FO-fed rats.  Rats fed SO had 
higher (P<0.005) hepatic stearic acid (18:0) content compared to the KO and MO-fed rats 
(Figure 6b).  There was no significant difference in liver palmitoleic acid (C16:1n-7) content 
among the diet groups (Figure 6c).  Liver oleic acid (C18:1n-9) content was higher (P<0.05) in 
the rats fed KO compared to FO diet (Figure 6d).   
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Gonadal Adipose Tissue  
Gonadal adipose palmitic acid (16:0) content was higher (P<0.005) in the MO compared 
to the SO and CO diet groups.  Gonadal adipose tissue palmitic acid was also higher (P=0.013) 
in rats fed the KO diet compared to rats fed the SO diet (Figure 7a).  There were no significant 
differences in adipose stearic acid (18:0) content among the diet groups (Figure 7b).  There were 
no significant differences in gonadal adipose palmitoleic acid (16:1n-7) and oleic acid (18:1n-9) 
among the diet groups (Figures 7c-d).   
5.6 Liver and Gonadal Adipose Tissue Lipolytic Gene Expression 
Liver Tissue 
PPARα gene expression was not significantly different in the n-3 PUFA diet groups 
compared to the CO diet group (Figure 8). 
Gonadal Adipose Tissue 
PPARγ gene expression was up-regulated in the FO diet group (P=0.039) compared to 
the CO diet group (Figure 9a).  There were no significant differences in HSL gene expression 
for the n-3 PUFA diet groups compared to the CO diet group (Figure 9b).   
5.7 Total Liver Triglyceride Content 
There were no significant differences in total liver TG content among the different diet 
groups (Figure 10). 
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5.8 Serum Lipids and Lipoproteins  
Serum total cholesterol concentration was lowest (P<0.001) in rats fed SO and TO diets.  
Rats fed KO and MO diets had significantly lower serum total cholesterol concentration 
compared to the rats fed FO and CO diets.  There were no significant differences in serum TG, 
VLDL, and LDL-C among the diet groups.  There was a significant decrease in HDL-C in rats 
fed FO and marine oils compared to rats fed the CO diet (Table 3).  
5.9 Liver and Gonadal Adipose Tissue Inflammation  
Liver Tissue 
In liver, there were no significant differences in COX 2 gene expression among the n-3 
PUFA diet groups compared to the CO diet group (Figure 11).  Hepatic IKBα gene expression 
was down-regulated in the FO (P=0.003), KO (P=0.04), SO (P=0.007), and TO (P=0.008) diet 
groups compared to the CO diet group (Figure 12).   
Gonadal Adipose Tissue 
COX 2 gene expression was not consistently detected in gonadal adipose tissue, 
therefore, gene expression was not measured.  In the gonadal adipose tissue, there were no 
significant differences in IKBα gene expression among rats fed the n-3 PUFA diets compared to 
the CO diet (Figure 13).  
5.10 Eicosanoids 
ARA-derived pro-inflammatory metabolites of PGE2 and TXB2 were measured in the 
urine.  There were no significant differences in urinary PGE2 metabolites (Figure 14a) and 
urinary TXB2 metabolites (Figure 14b) among the diet groups.   
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6.0 Discussion  
Serum Lipids and Lipoproteins 
Based on our results, rats fed marine sources of n-3 PUFAs (12% wt diet) significantly 
reduced serum total CHL compared to CO-fed rats.  Of the marine sources, rats fed SO and TO 
showed the greatest (P<0.05) reduction in serum total CHL.  Rats fed the n-3 PUFA sources also 
reduced (P<0.05) serum HDL-C compared to CO-fed rats.  Similarly, male spontaneously 
hypertensive rats fed fish oil (14% wt diet) lowered HDL-C concentrations compared to rats fed 
corn oil (12).  Healthy male Wistar rats fed fish oil (10% total calories)  had significantly lower 
HDL-C compared to rats fed sunflower oil rich in omega-6 fatty acids, olive oil rich in omega-9 
fatty acids, and  coconut oil rich in saturated fatty acids (54) (55) (56) (11).  Rodents, unlike 
humans, mainly transport cholesterol in the HDL fraction (36).  Therefore, reduced HDL-C 
indicates reduced circulating cholesterol in rats.  Since SCD-1 plays a role in synthesis of 
MUFAs (16:1 and 18:1) which regulates TG and CHL biosynthesis, the effects of different n-3 
PUFA sources on lipogenic gene expression were analyzed (57).  
Lipogenesis 
Although, liver total TG content was not significantly different among the n-3 PUFA diet 
groups, different sources of n-3 PUFAs had different effects on lipogenic gene expression.  TO 
and SO-fed rats had the lowest (P<0.05) serum total CHL.  Rats fed TO had no significant effect 
on lipogenic transcription factor SREBP1c, but down-regulated FAS (P=0.006) gene expression 
compared to CO-fed rats.  FAS end product, SFA 16:0 was significantly increased rather than 
decreased in rats fed TO compared to CO and FO diet.  SFA, 18:0 was also significantly 
increased in TO compared to FO and KO-fed rats.  Accumulation of SFAs may be due to 
decreased desaturation to MUFAs due to down-regulated (P=0.04) SCD-1 in TO compared to 
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CO-fed rats.  However, SCD-1 end products MUFAs, 16:1 and 18:1were not significantly 
reduced.  There were no significant differences in dietary SFA content among the diets, but 
tissue MUFA content may have been confounded due to differences in dietary MUFA content 
among the diets.  TO had higher (P<0.001) hepatic DHA deposition compared to the MO, KO, 
FO, and CO diet groups and the lowest (P<0.05) hepatic EPA:DHA ratio.  Increased hepatic 
DHA may have directly influenced FAS and SCD-1 rather than through the lipogenic 
transcription factor, SREBP-1c. 
Similar to rats fed TO, the SO-fed rats had the lowest total serum CHL and decreased 
FAS (P=0.001) gene expression.  However, the SO diet group had no significant effect on SCD-
1 or SREBP-1c gene expression.  Rats fed SO had the highest (P<0.001) EPA hepatic deposition 
among the diet groups.  Male Wistar rats fed a high (62% energy, dry weight) fat diet 
supplemented with EPA had no significant effect on hepatic SREBP-1c expression (9).  Both 
EPA and DHA, had no effect on lipogenic transcription factor SREBP-1c gene expression, but 
may have acted directly on lipogenic enzymes.  Despite decreased FAS gene expression and no 
effect on SCD-1, hepatic 16:0 was significantly increased in rats fed SO compared to MO, FO, 
and CO diet.  Also, 18:0 was increased in SO compared to MO, KO, and FO-fed rats.  This may 
be because when dietary n-3 LC-PUFAs are provided, less SFAs may be desaturated by the 
body.  Both SO and TO-fed rats decreased FAS gene expression, but only TO-fed rats decreased 
SCD-1 gene expression.  TO and SO-fed rats had similar hepatic DHA content, but hepatic EPA 
content was highest (P<0.001) in the SO diet group.  This resulted in TO-fed rats having the 
lowest (P<0.05) hepatic tissue EPA:DHA ratio.  Based on the results, EPA had no effect on 
SCD-1 gene expression, but decreased tissue EPA:DHA ratio decreased SCD-1 gene expression.  
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Of the n-3 PUFA sources, only the MO diet caused a down-regulation in SREBP-1c, 
FAS, and SCD-1 (P<0.05) gene expression compared to the CO diet.  Reduced hepatic SFAs, 
16:0 and 18:0 content in MO compared to SO and TO-fed rats suggested reduced lipogenesis due 
to down-regulated FAS gene expression.  Similarly, FAS gene expression was down-regulated in 
male rats fed 10% MO (6).  In our study, rats fed MO down–regulated hepatic SCD-1 gene 
expression, but had no significant effect on end products MUFAs, 16:1 and 18:1 possibly due to 
higher (P<0.05) dietary 16:1 content in MO compared to CO, FO, and KO diets.  Lu et al. (2) 
reported hepatic SREBP-1 gene expression and  SREBP-1 and FAS protein expression were 
down-regulated  in male obese rats fed high cholesterol diets supplemented with 5% n-3 PUFA 
mixture of fish oil derived EPA and DHA.  In our study, rats fed MO had lower (P<0.001) 
hepatic EPA deposition compared to SO-fed rats and lower (P<0.001) hepatic DHA deposition 
compared TO and SO-fed rats.  However, hepatic ARA deposition was lower (P<0.001) in the 
MO compared to TO and SO-fed rats. The results suggested that ARA affected lipogenesis 
through transcription factor SREBP-1c whereas, EPA and DHA regulated lipogenic gene 
expression independent of SREBP-1c.  Therefore, SO and TO, and not MO, had the lowest 
serum total CHL.   
KO diet had the highest EPA and DHA, yet rats fed KO had no significant effects on 
SREBP-1c, FAS, or SCD-1 gene expression.  Despite higher dietary n-3 LC-PUFA content, 
hepatic EPA deposition in rats fed KO was significantly lower than SO-fed rats and hepatic 
DHA content was significantly lower than SO and TO-fed rats.  Fatty acids in KO are in both PL 
and TG form; whereas, fish oil (SO, TO, and MO) fatty acids are mainly in TG form (24).  The 
results indicated lower liver deposition when n-3 LC-PUFAs are fed in PL form and in turn, this 
resulted in no significant effects on hepatic tissue lipogenic gene expression in rats fed KO.    
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Rats fed FO down-regulated FAS gene expression, but had no effect on SCD-1 or 
SREBP-1c gene expression.  The FO group diet contains high amounts of ALA and 
subsequently, had the highest (P<0.001) hepatic ALA content.  Despite higher dietary 18:0 
content, FO-fed rats down-regulated FAS and decreased hepatic 16:0 content compared to SO 
and TO-fed rats and decreased hepatic 18:0 content compared to TO-fed rats.  Dietary 18:1 
content was higher (P<0.05) in FO compared to MO, TO, and SO diets, yet hepatic 18:1 
deposition was not significantly different compared to the other n-3 PUFA groups, except KO.  
Higher dietary 18:1 content in FO may be transported to extrahepatic tissues as indicated by the 
increased (P<0.05) serum total CHL compared to marine oils.         
In gonadal adipose tissue, there were no differences in gene expression of SREBP-1c, 
FAS, or SCD-1 among rats fed the different n-3 PUFA sources.  In contrast, male mice fed a 
high (20% wt) fat diet consisting of an n-3 PUFA concentrate (6% EPA and 51% DHA as 44% 
total lipid; 56% flaxseed oil as total lipid) significantly down-regulated SCD-1 gene expression 
in epididymal fat compared to male mice fed a high fat diet supplemented with 100% flaxseed 
oil (15).  This study differed from our study because n-3 PUFA concentrate instead of pure oils 
was used.  Also, male rather than female rats were studied (15).  Gender differences may exist in 
n-3 PUFA metabolism with females having more efficient conversion of ALA to EPA and DHA 
due to lower partitioning of ALA towards beta-oxidation and higher activity of the desaturation–
elongation pathway (13).  Mulhausler et al. (18) fed female rats differing amounts of ALA 
(0.095%, 0.19%, 0.38%, 0.76%, 1.00%, 2.05%, 4.1%, and 6.3% total energy).  Gene expressions 
of SREBP-1c, FAS, and SCD-1 increased until a level of 0.38% to 0.76% ALA in the diet.  
Further increases in ALA dose decreased or had no significant effect on gene expression (18).  
Although lipid metabolism occurs in the adipose tissue, it does not contribute to a significant 
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portion of lipogenesis (29).  Instead, adipose tissue consists mainly of lipids both dietary and de 
novo synthesized in the liver and transported to the adipose tissue where they are stored until 
required for lipolysis (58).   
Lipolysis 
HSL releases fatty acids stored in the adipose tissue.  In our study, HSL expression was 
not significantly different in the n-3 PUFA diet groups compared to the CO diet group.  PPARγ 
is a transcription factor that regulates lipid storage in adipose tissue (29).  In our study, gonadal 
adipose PPARγ gene expression was up-regulated (P=0.039) in FO compared to CO-fed rats.  In 
contrast, PPARγ was unchanged in omental adipose tissue of female Agouti rats fed differing 
doses of flaxseed oil (0.095% to 6.3% of total energy) (18).  Our study provided a higher dose 
ALA of 27% of kcal compared to 6.3% of kcal.  In our study, rats fed ALA-rich FO resulted in 
EPA and DHA deposition in the adipose tissue.  Therefore, up-regulated PPARγ gene expression 
may be due to the increased EPA:DHA ratio in gonadal adipose tissue.     
Fatty acids released by the adipose tissue can be taken up by tissue for oxidation.  PPARα 
is a transcription factor that regulates the expression of a number of genes involved in hepatic 
mitochondrial and peroxisome fatty acid oxidation.  Our study found no differences in hepatic 
PPARα gene expression among the diet groups.  Similarly, male Hooded-Wistar rats (age 3 
weeks) fed differing doses (0.2, 0.5, 1.0, 1.9, 2.9%) of ALA from flaxseed oil had no significant 
effect on hepatic PPARα gene expression (30).  However, male Wistar rats provided EPA ethyl 
ester supplements resulted in a significant down-regulation of hepatic PPARα gene expression 
(9).  Purified EPA ethyl ester supplementation provides a higher dose of EPA than when 
provided as an oil source. 
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In our study, the MO diet lowered hepatic ARA content and down-regulated transcription 
factor SREBP-1c gene expression, which subsequently down-regulated FAS and SCD-1 gene 
expression, suggesting decreased lipogenesis.  All n-3 PUFA sources (except KO) reduced 
lipogenic enzyme FAS, but only the rats fed MO and TO diets decreased EPA:DHA ratio which 
down-regulated the desaturase enzyme SCD-1.  In adipose tissue, the FO diet increased 
EPA:DHA ratio and up-regulated  PPARγ expression suggesting increased lipolysis.  Since the 
anti-inflammatory effects of n-3 PUFAs, specifically EPA and DHA, are partly mediated through 
PPARγ (59); our study evaluated the effects of tissue fatty acid changes on inflammation.  
Inflammation 
Of the n-3 PUFA sources, only rats fed FO up-regulated (P=0.039) PPARγ gene 
expression compared to CO.  FO-fed rats had the highest (P<0.05) gonadal adipose tissue 
EPA:DHA ratio.  Another key transcription factor regulating inflammation is NFKB.  IKBα is 
the inhibitory subunit of NFKB.  Phosphorylation degrades IKBα and activates NFKB (48).  
Therefore, IKBα is up-regulated when NFKB is activated (60).  In our study, hepatic IKBα gene 
expression was significantly down-regulated in rats fed FO, KO, SO, and TO compared to rats 
fed CO.  THP-1 cell line stimulated by LPS and treated with EPA resulted in suppressed 
phosphorylated IKBα levels, indicating that EPA prevents IKBα degradation and subsequent 
NFKB translocation/activation by preventing phosphorylation of IKBα (48).  The KO group had 
the highest (P<0.05) gonadal adipose EPA content, and the MO group had higher (P=0.007) 
gonadal adipose EPA content than the FO group.  However, MO was the only diet that did not 
significantly down-regulate IKBα, yet down-regulated lipogenic transcription factor SREBP-1c.   
Anti-inflammatory effects can also be exerted through other pathways; therefore, our study also 
determined de novo synthesis of the eicosanoids by the COX 2 pathway.  ARA, an n-6 PUFA, 
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synthesizes “pro-inflammatory” PGE2 or TXB2 through the COX 2 pathway.  In our study, rats 
fed MO had the lowest hepatic ARA content.  However there were no significant differences in 
hepatic COX 2 gene expression or urinary PGE2 or TXB2 metabolite concentrations in the n-3 
PUFA diet groups compared to CO diet group.  Gene expression of the COX 2 enzyme is 
typically up-regulated in disease and inflammatory conditions (44).  Our study used non-diseased 
animals.  Sankaran et al. (44) reported that n-3 LC-PUFAs attenuate the increase in COX 2 
expression in diseased animal models.   In contrast, normal Han:SPRD-cy rats fed a high fat (20g 
fat/100g diet) diet consisting of cottonseed oil rich in n-6 PUFA or MO + soybean oil rich in 
ALA, EPA and DHA resulted in no statistical differences in renal COX 2 mRNA and protein 
levels (44).  Therefore, attenuation of COX 2 expression by n-3 PUFAs may be specific to 
diseased models.   
 
7.0 Conclusion 
In conclusion, different type and structural forms of n-3 LC-PUFAs exerted different 
effects on lipogenic gene expression and lipid metabolism.  Feeding rats MO resulted in lower 
(P<0.001) hepatic ARA content than SO and TO and down-regulated gene expression of the 
transcription factor SREBP-1c, which subsequently down regulated FAS and SCD-1.  All n-3 
PUFAs sources in TG form down-regulated FAS gene expression.  Only MO and TO-fed rats 
down-regulated SCD-1 gene expression.   None of the n-3 PUFAs sources altered lipogenic gene 
expression in the adipose tissue.  On the other hand, FO had the highest gonadal adipose tissue 
(P<0.05) EPA:DHA ratio and was the only n-3 PUFA source that up-regulated adipose tissue 
PPARγ, lipolytic gene expression.    
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All n-3 PUFA sources reduced serum HDL-C levels.  Additionally, marine sources of n-3 
PUFAs reduced serum total cholesterol, particularly SO and TO, due to the high dietary EPA and 
DHA content.  Rats fed n-3 LC-PUFA sources, with the exception of the MO diet, decreased 
inflammation indicated by down-regulated hepatic IKBα gene expression.  Despite resulting in 
the lower hepatic ARA content, in rats fed MO there was no effect on COX 2 gene expression or 
2-series eicosanoids.  The study results showed that different n-3 LC-PUFA sources had various 
effects on risk factors for CVD such as changing the balance of lipogenesis and lipolysis gene 
expression, altering circulating lipids, and inflammation.  Therefore, different n-3 PUFA sources 
have altered certain, but not all CVD risk factors.  
 
8.0 Future Research 
Studies of the beneficial effects of n-3 PUFA consumption are constantly emerging, 
resulting in the food industry fortifying various food products with n-3 PUFAs.  This study 
showed that n-3 PUFAs affected gene transcription.  Further research needs to determine 
whether the n-3 PUFAs also affected translation, since some end products did not match changes 
in gene expression.  This can be achieved by measuring subsequent changes in protein 
expression and enzyme activity.  Additionally, further research needs to determine whether tissue 
deposition of fatty acids was from a dietary source or de novo synthesis, which can be 
investigated utilizing a tracer, such as radiolabeling carbons.  In our study, results also showed n-
3 PUFAs had different effects on serum lipids, serum lipoproteins, and inflammation.  Oxidized 
LDL-C and cellular oxidative stress induced by modification of lipids by reactive oxygen species 
can induce NFKB mediated transcription of inflammation-related genes such as interleukin-8 
(61).  Therefore, future studies should investigate whether the reported inconsistent serum lipid 
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and lipoprotein results may be exerted through the inflammation cascade in order to determine 
the anti-atherosclerotic effects of n-3 PUFA consumption.     
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Table 1. Diet Characteristics 
 Oil Source Acronym Characteristic 
Plant Sources Corn  CO Control (Western diet) 
Flaxseed FO Highest ALA 
Marine Sources Krill KO Highest n-3 PUFA 
Salmon SO Highest EPA of fish oil sources, highest EPA:DHA ratio 
Tuna TO Highest DHA of fish oil sources, lowest EPA:DHA ratio 
Menhaden MO Contains n-3 PUFAs in lesser amounts than other groups 
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Table 2. Genes Analyzed 
Gene Gene ID Tissue Function Metabolism 
GAPDH  24383 Liver, Adipose Housekeeping gene  
SREBP-1c 78968 Liver, Adipose Transcription Factor Lipogenesis 
FAS 50671 Liver, Adipose Enzyme Lipogenesis 
SCD-1 246074 Liver, Adipose Enzyme Lipogenesis 
PPARα 25747 Liver Transcription Factor Lipolysis 
PPARγ 25664 Adipose Transcription Factor Lipolysis/Inflammation 
HSL 25330 Adipose Enzyme Lipolysis 
IKBα 25493   
 
Liver, Adipose Regulatory protein that 
inhibits NFKB 
Inflammation 
COX 2 29527 Liver Rate limiting enzyme Eicosanoid 
synthesis/Inflammation 
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Table 3.  Dietary fatty acids and lipid classes. 
 Treatments 
Fatty Acids (mg FA/g Diet) CO FO KO MO SO TO 
SFA       
Palmitic Acid (C16:0)
1 
1.0±0.2 1.4±0.2 2.0±0.5 2.0±0.2 2.0±0.2 1.7±0.2 
Stearic Acid (C18:0)
1 
0.2±0.02
b 
1.2±0.2
a 
0.3±0.1
b 
0.4±0.03
b 
0.4±0.03
b 
0.5±0.04
b 
MUFA       
Palmitoleic (16:1n-7)
1 0.02±0.005
b 
0.03±0.002
b 
0.8±0.4
b 
2.5±0.2
a 
3.09±0.4
a 
2.5±0.2
a 
Oleic (18:1n-9)
1 1.6±0.4
ab 
3.08±0.2
a 
1.6±0.7
ab 
0.9±0.07
b 
1.3±0.2
b 
1.3±0.1
b 
n-3 PUFA       
ALA (18:3n-3)
1 
0.1 ± 0.01
b 
14.6 ± 2.1
a 
0.2 ± 0.04
b 
0.2 ± 0.01
b 
0.1 ± 0.01
b 
0.1 ± 0.01
b 
EPA (20:5n-3)
1 
ND ND 13.2 ± 2.8
a 
5.5 ± 0.4
bc 
10.0 ± 0.7
ab 
2.6 ± 0.3
c 
DHA (22:6n-3)
1 
ND ND 4.6 ± 1.9 2.0 ± 0.2 1.9 ± 0.1 2.9 ± 0.2 
EPA/DHA ND ND 3:1 3:1 5:1 1:2 
n-6 PUFA       
LA (18:2n-6)
1 
6.4 ± 0.9
a 
5.4 ± 0.8
a 
0.5 ± 0.1
b 
0.2 ± 0.1
b 
0.5 ± 0.1
b 
0.2 ± 0.03
b 
ARA (20:4n-6)
1 
ND ND 0.23 ± 0.04 0.16 ± 0.01 0.22 ± 0.01 0.30 ± 0.1 
n-6/n-3
2 73:1 1:3 1:33 1:48 1:23 1:12 
1
Values are expressed as mean ± SEM, n=3-4 replicates/diet. 
2
Values are expressed as mean (%) ± SEM  
Abbreviations are: CO, corn oil; FO, flaxseed oil; KO, krill oil; MO, menhaden oil; SO, salmon oil; TO, tuna oil.; SFA, saturated fatty 
acids; PUFA, polyunsaturated fatty acids; LA, linolenic acid; ARA, arachidonic acid; ALA, α-linolenic acid; EPA, eicosapentaenoic 
acid; DHA, docosahexaenoic acid; ND, not detectable.
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Figure 4a: The Effect of Feeding Growing Female Rats Different Sources of Omega-3 Polyunsaturated Fatty Acids on the 
mRNA Expression of SREBP-1c in Hepatic Tissue.   
 
Expression compared to CO group and normalized to GAPDH.  (*P<0.05 indicates down regulation, n=5 rats/group).  Gene 
expression was analyzed by pairwise fixed reallocation randomization test.  Abbreviations are CO, corn oil; FO, flaxseed oil; KO, krill 
oil; MO, menhaden oil; SO, salmon oil; TO, tuna oil. 
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Figure 4b: The Effect of Feeding Growing Female Rats Different Sources of Omega-3 Polyunsaturated Fatty Acids on the 
mRNA Expression of FAS in Hepatic Tissue.   
 
Expression compared to CO group and normalized to GAPDH.  (* P<0.05 indicates down regulation, n=5 rats/group).  Gene 
expression was analyzed by pairwise fixed reallocation randomization test.  Abbreviations are CO, corn oil; FO, flaxseed oil; KO, krill 
oil; MO, menhaden oil; SO, salmon oil; TO, tuna oil. 
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Figure 4c: The Effect of Feeding Growing Female Rats Different Sources of Omega-3 Polyunsaturated Fatty Acids on the 
mRNA Expression of SCD-1 in Hepatic Tissue.   
 
Expression compared to CO group and normalized to GAPDH.  (* P<0.05 indicates down regulation, n=5 rats/group).  Gene 
expression was analyzed by pairwise fixed reallocation randomization test.  Abbreviations are CO, corn oil; FO, flaxseed oil; KO, krill 
oil; MO, menhaden oil; SO, salmon oil; TO, tuna oil. 
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Figure 5a: The Effect of Feeding Growing Female Rats Different Sources of Omega-3 Polyunsaturated Fatty Acids on the 
mRNA Expression of SREBP-1c in Gonadal Adipose Tissue.   
 
Expression compared to CO group and normalized to GAPDH.  (*P<0.05 indicates down regulation, n=5 rats/group).  Gene 
expression was analyzed by pairwise fixed reallocation randomization test.  Abbreviations are CO, corn oil; FO, flaxseed oil; KO, krill 
oil; MO, menhaden oil; SO, salmon oil; TO, tuna oil. 
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Figure 5b: The Effect of Feeding Growing Female Rats Different Sources of Omega-3 Polyunsaturated Fatty Acids on the 
mRNA Expression of FAS in Gonadal Adipose Tissue.  
 
Expression compared to CO group and normalized to GAPDH.  (*P<0.05 indicates down regulation, n=5 rats/group).  Gene 
expression was analyzed by pairwise fixed reallocation randomization test.  Abbreviations are CO, corn oil; FO, flaxseed oil; KO, krill 
oil; MO, menhaden oil; SO, salmon oil; TO, tuna oil. 
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Figure 5c: The Effect of Feeding Growing Female Rats Different Sources of Omega-3 Polyunsaturated Fatty Acids on the 
mRNA levels of SCD-1 in Gonadal Adipose Tissue.   
 
Expression compared to CO group and normalized to GAPDH.  (* P<0.05 indicates down regulation, n=5 rats/group.  Gene 
expression was analyzed by pairwise fixed reallocation randomization test.  Abbreviations are CO, corn oil; FO, flaxseed oil; KO, krill 
oil; MO, menhaden oil; SO, salmon oil; TO, tuna oil. 
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Figure 6a: The Effect of Feeding Growing Female Rats Different Sources of Omega-3 Polyunsaturated Fatty Acids on Liver 
Palmitic Acid (16:0) Content.  
Values are expressed as the mean (mg FA/g tissue) + SEM of n=10 rats/group. Different superscript letters a, b, c indicate significant 
differences at P<0.05 by one-way ANOVA followed by Tukey’s test. Abbreviations are CO, corn oil; FO, flaxseed oil; KO, krill oil; 
MO, menhaden oil; SO, salmon oil; TO, tuna oil. 
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Figure 6b: The Effect of Feeding Growing Female Rats Different Sources of Omega-3 Polyunsaturated Fatty Acids on Liver 
Stearic Acid (18:0) Content.  
Values are expressed as the mean (mg FA/g tissue) + SEM of n=10 rats/group. Different superscript letters a, b, c indicate significant 
differences at P<0.05 by one-way ANOVA followed by Tukey’s test. Abbreviations are CO, corn oil; FO, flaxseed oil; KO, krill oil; 
MO, menhaden oil; SO, salmon oil; TO, tuna oil. 
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Figure 6c: The Effect of Feeding Growing Female Rats Different Sources of Omega-3 Polyunsaturated Fatty Acids on Liver 
Palmitoleic Acid (16:1n-7) Content.  
Values are expressed as the mean (mg FA/g tissue) + SEM of n=5 rats/group. Different superscript letters a, b, c indicate significant 
differences at P<0.05 by one-way ANOVA followed by Tukey’s test. Abbreviations are CO, corn oil; FO, flaxseed oil; KO, krill oil; 
MO, menhaden oil; SO, salmon oil; TO, tuna oil. 
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Figure 6d: The Effect of Feeding Growing Female Rats Different Sources of Omega-3 Polyunsaturated Fatty Acids on Liver 
Oleic Acid (18:1n-9) Content.  
Values are expressed as the mean (mg FA/g tissue) + SEM of n=5 rats/group. Different superscript letters a, b, c indicate significant 
differences at P<0.05 by one-way ANOVA followed by Tukey’s test. Abbreviations are CO, corn oil; FO, flaxseed oil; KO, krill oil; 
MO, menhaden oil; SO, salmon oil; TO, tuna oil. 
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Figure 7a: The Effects of Feeding Growing Female Rats Different Sources of Omega-3 Polyunsaturated Fatty Acids on 
Gonadal Adipose Tissue Palmitic Acid (16:0) Content. 
Values are expressed as the mean + SEM of n=10 rats/group. Different superscript letters a, b, c indicate significant differences at 
P<0.05 by one-way ANOVA followed by Tukey’s test. Abbreviations are CO, corn oil; FO, flaxseed oil; KO, krill oil; MO, menhaden 
oil; SO, salmon oil; TO, tuna oil. 
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Figure 7b: The Effects of Feeding Growing Female Rats Different Sources of Omega-3 Polyunsaturated Fatty Acids on 
Gonadal Adipose Tissue Stearic Acid (18:0) Content.  
Values are expressed as the mean + SEM of n=10 rats/group. Different superscript letters a, b, c indicate significant differences at 
P<0.05 by one-way ANOVA followed by Tukey’s test. Abbreviations are CO, corn oil; FO, flaxseed oil; KO, krill oil; MO, menhaden 
oil; SO, salmon oil; TO, tuna oil. 
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Figure 7c: The Effects of Feeding Growing Female Rats Different Sources of Omega-3 Polyunsaturated Fatty Acids on 
Gonadal Adipose Tissue Palmitoleic Acid (16:1n-7) Content. 
 
Values are expressed as the mean + SEM of n=4-5 rats/group. Different superscript letters a, b, c indicate significant differences at 
P<0.05 by one-way ANOVA followed by Tukey’s test. Abbreviations are CO, corn oil; FO, flaxseed oil; KO, krill oil; MO, menhaden 
oil; SO, salmon oil; TO, tuna oil. 
58 
 
Figure 7d: The Effects of Feeding Growing Female Rats Different Sources of Omega-3 Polyunsaturated Fatty Acids on 
Gonadal Adipose Tissue Oleic Acid (18:1n-9) Content. 
 
Values are expressed as the mean + SEM of n=4-5 rats/group. Different superscript letters a, b, c indicate significant differences at 
P<0.05 by one-way ANOVA followed by Tukey’s test. Abbreviations are CO, corn oil; FO, flaxseed oil; KO, krill oil; MO, menhaden 
oil; SO, salmon oil; TO, tuna oil. 
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Figure 8: The Effect of Feeding Growing Female Rats Different Sources of Omega-3 Polyunsaturated Fatty Acids on the 
mRNA Expression of PPARα in Hepatic Tissue.   
 
Expression compared to CO group and normalized to GAPDH.  (*P<0.05 indicates up- regulation, n=5 rats/group).  Gene expression 
was analyzed by pairwise fixed reallocation randomization test.  Abbreviations are CO, corn oil; FO, flaxseed oil; KO, krill oil; MO, 
menhaden oil; SO, salmon oil; TO, tuna oil. 
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Figure 9a: The Effect of Feeding Growing Female Rats Different Sources of Omega-3 Polyunsaturated Fatty Acids on the 
mRNA Expression of PPARγ in Gonadal Adipose Tissue.   
 
Expression compared to CO group and normalized to GAPDH.  (*P<0.05 indicates up-regulation, n=4-5 rats/group).  Gene expression 
was analyzed by pairwise fixed reallocation randomization test.  Abbreviations are CO, corn oil; FO, flaxseed oil; KO, krill oil; MO, 
menhaden oil; SO, salmon oil; TO, tuna oil. 
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Figure 9b: The Effect of Feeding Growing Female Rats Different Sources of Omega-3 Polyunsaturated Fatty Acids on the 
mRNA Expression of HSL in Gonadal Adipose Tissue. 
 
Expression compared to CO group and normalized to GAPDH.  (*P<0.05 indicates up-regulation, n=5 rats/group).  Gene expression 
was analyzed by pairwise fixed reallocation randomization test.  Abbreviations are CO, corn oil; FO, flaxseed oil; KO, krill oil; MO, 
menhaden oil; SO, salmon oil; TO, tuna oil. 
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Figure 10: The Effect of Feeding Growing Female Rats Different Sources of Omega-3 Polyunsaturated Fatty Acids on Liver 
Total Triglyceride Content. 
Values are expressed as mean (mg/dl) ±SEM, n=5 rats/group.  Different superscript letters a, b, c indicate significant differences at 
P<0.05 by one-way ANOVA followed by Tukey’s test. Abbreviations are CO, corn oil; FO, flaxseed oil; KO, krill oil; MO, menhaden 
oil; SO, salmon oil; TO, tuna oil; TG, triglyceride.    
63 
 
Table 4: The Effect of Feeding Growing FemaleRats Different Sources of Omega-3 Polyunsaturated Fatty Acids on Serum Lipids and 
Lipoproteins. 
Measurement CO FO KO MO SO TO 
Total CHL 
(mg/dl) 
144.9±8.4
a 
117.5±3.6
a 
104.3±5.4
b 
101.8±3.7
b 
61.7±5.2
c 
58.4±1.6
c 
Total TG 
(mg/dl) 
89.9±6.4 88.6±6.7 97.7±12.1 80.4±5.1 82.9±7.3 76.4±6.1 
VLDL 
(mg/dl) 
18.0±1.3 17.7±1.3 19.6±2.4 16.2±1.0 16.8±1.5 15.2±1.2 
LDL-C 
(mg/dl) 
6.4±3.2 17.9±4.2 10.6±4.4 9.2±2.3 13.1±5.2 4.2±2.2 
HDL-C 
(mg/dl) 
56.8±4.81
a
 34.99±2.98
b 
31.49±3.84
b 
26.35±2.48
b 
24.68±1.74
b 
29.27±1.46
b 
Values are expressed as mean ± SEM, n=5-10 rats/group.  Different superscript letters a, b, c within the same rows indicate significant 
differences at P<0.05 by one-way ANOVA followed by Tukey’s test.   Abbreviations are cholesterol (CHL), triglyceride (TG), very 
low density lipoprotein (VLDL), low density lipoprotein (LDL-C), high density lipoprotein (HDL-C), corn oil (CO), flaxseed oil (FO), 
krill oil (KO), menhaden oil (MO), salmon oil (SO), tuna oil (TO). 
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Figure 11: The Effect of Feeding Growing Female Rats Different Sources of Omega-3 Polyunsaturated Fatty Acids on the 
mRNA Expression of COX 2 in Hepatic Tissue. 
 
Expression compared to CO group and normalized to GAPDH.  (*P<0.05 indicates down regulation, n=5 rats/group).  Gene 
expression was analyzed by pairwise fixed reallocation randomization test.  Abbreviations are CO, corn oil; FO, flaxseed oil; KO, krill 
oil; MO, menhaden oil; SO, salmon oil; TO, tuna oil. 
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Figure 12: The Effect of Feeding Growing Female Rats Different Sources of Omega-3 Polyunsaturated Fatty Acids on the 
mRNA Expression of IKBα in Hepatic Tissue.   
 
Expression compared to CO group and normalized to GAPDH.  (*P<0.05 indicates down regulation, n=5 rats/group).  Gene 
expression was analyzed by pairwise fixed reallocation randomization test.  Abbreviations are CO, corn oil; FO, flaxseed oil; KO, krill 
oil; MO, menhaden oil; SO, salmon oil; TO, tuna oil. 
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Figure 13: The Effect of Feeding Growing Female Rats Different Sources of Omega-3 Polyunsaturated Fatty Acids on the 
mRNA Expression of IKBα in Gonadal Adipose Tissue.   
  
Expression compared to CO group and normalized to GAPDH.  (*P<0.05 indicates down regulation, n=5 rats/group).  Gene 
expression was analyzed by pairwise fixed reallocation randomization test.  Abbreviations are CO, corn oil; FO, flaxseed oil; KO, krill 
oil; MO, menhaden oil; SO, salmon oil; TO, tuna oil. 
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Figure 14a: The Effect of Feeding Growing Female Rats Different Sources of Omega-3 Fatty Acids on Urinary Levels of PGE2 
Metabolite. 
 
Values are expressed as the mean + SEM of n=7 rats/group. Different superscript letters a, b, c indicate significant differences at 
P<0.05 by one-way ANOVA followed by Tukey’s test. Abbreviations are CO, corn oil; FO, flaxseed oil; KO, krill oil; MO, menhaden 
oil; SO, salmon oil; TO, tuna oil; PGE2, prostaglandin E2. 
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Figure 14b: The Effect of Feeding Growing Female Rats Different Sources of Omega-3 Fatty Acids on Urinary TXB2 
Metabolite. 
 
Values are expressed as the mean + SEM of n=7 rats/group. Different superscript letters a, b, c indicate significant differences at 
P<0.05 by one-way ANOVA followed by Tukey’s test. Abbreviations are CO, corn oil; FO, flaxseed oil; KO, krill oil; MO, menhaden 
oil; SO, salmon oil; TO, tuna oil; TXB2, thromboxane B2. 
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Appendices 
Appendix 1.  Whole Diet Composition. 
 Treatments 
Ingredients (g/kg diet) CO FO KO MO SO  TO 
ω-3  PUFA Oil Source 0 120 118 118 120 120 
Corn Oil 120 0 2 2 0 0 
Casein 200 200 200 200 200 200 
L-Cystine 3 3 3 3 3 3 
Corn Starch 347.5 347.5 347.5 347.5 347.5 347.5 
Maltodextrin 132 132 132 132 132 132 
Sucrose 100 100 100 100 100 100 
Cellulose 50 50 50 50 50 50 
Mineral Mix, AIN-93G-MX* 35 35 35 35 35 35 
Vitamin Mix, AIN-93-VX* 10 10 10 10 10 10 
Choline Bitartrate 2.5 2.5 2.5 2.5 2.5 2.5 
Based on the AIN-93G vitamin and mineral mixes (Reeves et al., 1993). Abbreviations are CO, corn oil; FO, flaxseed oil; KO, krill 
oil; MO, menhaden oil; SO, salmon oil; TO, tuna oil.
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Appendix 2.  The Effect of Feeding Growing Female Rats Different Sources of Omega-3 Polyunsaturated Fatty Acids on Food 
Intake, Body Weight, and Tissue Weights. 
 Treatments 
Measurement CO FO KO MO SO TO 
Food intake (g) 750.1 ± 12.5 762.9 ± 14.3 767.4 ± 10.9 761.2 ± 17.6 706.8 ± 17.4 738.3 ± 16.4 
Body weight gain (g) 76.0 ± 7.4 103.8 ± 8.1 98.4 ± 6.1 107.6 ± 12.5 86.0 ± 8.4 106.0 ± 6.7 
Final body weight (g) 214.9 ± 6.4 239.6 ± 8.2 231.7 ± 6.6 241.5 ± 14.4 215.5 ± 10.3 235.0 ± 8.2 
Liver weight (g/100g bwt) 2.9 ± 0.1
c 
2.8 ± 0.1
c 
3.6 ±0.1
ab 
3.2 ± 0.2
bc 
3.7 ± 0.1
a 
3.8 ± 0.1
a 
Gonadal adipose weight (g/100 g bwt) 1.1 ± 0.2 1.7 ± 0.2 1.6 ± 0.1 1.8 ± 0.4 1.3 ± 0.2 1.3 ± 0.2 
Values are expressed as the mean + SEM of n=10 rats/group. Different superscript letters a, b, c within the same rows indicate 
significant differences at P<0.05 by one-way ANOVA followed by Tukey’s test. Abbreviations are CO, corn oil; FO, flaxseed oil; 
KO, krill oil; MO, menhaden oil; SO, salmon oil; TO, tuna oil; bwt, body weight.  
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Appendix 3.  The Effect of Feeding Growing Female Rats Different Sources of Omega-3 Polyunsaturated Fatty Acids on Liver Fatty 
Acid Profile. 
 
 Treatments 
Fatty Acid Measurement CO FO KO MO SO  TO 
n-3 PUFA
 0.9 ± 0.1
b 
7.8 ± 1.0
b 
9.6 ± 1.3
b 
9.5 ± 1.1
b 
43.6 ± 5.8
a 
35.9 ± 2.5
a
 
ALA (18:3n-3)
 
0.1 ± 0.01
b 
4.4 ± 0.7
a 
0.1 ± 0.01
b 
0.3 ± 0.1
b 
0.3 ± 0.1
b 
0.2 ± 0.04
b 
EPA (20:5n-3)
 
ND 1.7 ± 0.2
b 
3.7 ± 0.5
b 
3.0 ± 0.6
b 
19.4 ± 3.1
a 
6.3 ± 0.6
b 
DHA (22:6n-3)
 
0.9 ± 0.1
b 
1.7 ± 0.2
b 
5.7 ± 0.8
b 
6.2 ± 0.7
b 
23.8 ± 2.9
a 
29.4 ± 2.0
a 
EPA/DHA ND 1.0 ± 0.1
a 
0.7 ± 0.1
bc 
0.5 ± 0.1
c 
0.8 ± 0.1
ab 
0.2 ± 0.01
d 
n-6 PUFA
 11.9 ± 0.9
a 
5.9 ± 0.9
b 
3.0 ± 0.1
c 
2.7 ± 0.3
c 
6.7 ± 0.6
b 
7.6 ± 0.5
b 
LA (18:2n-6)
 
7.1 ± 0.7
a 
4.1 ± 0.7
b 
1.4 ± 0.1
c 
1.3 ± 0.2
c 
2.0 ± 0.4
c 
1.6 ± 0.2
c 
ARA (20:4n-6)
 
4.8 ± 0.3
b 
1.9 ± 0.3
c 
1.6 ± 0.1
c 
1.4 ± 0.1
c 
4.7 ± 0.3
b
 6.0 ± 0.4
a 
n-6/n-3 14.6 ± 1.6
a 
0.8 ± 0.1
b 
0.4 ± 0.04
b 
0.3 ± 0.02
b 
0.2 ± 0.02
b 
0.2 ± 0.01
b 
Values are expressed as mean (mg FA/g tissue) ± SEM of n=10 rats/group.  Different superscript letters a, b, c, d within the same rows 
indicate significant differences at P<0.05 by one-way ANOVA followed by Tukey’s test (parametric). Abbreviations are: CO, corn 
oil; FO, flaxseed oil; KO, krill oil; MO, menhaden oil; SO, salmon oil; TO, tuna oil.; SFA, saturated fatty acids; PUFA, 
polyunsaturated fatty acids; LA, linoleic acid; ARA, arachidonic acid; ALA, α-linolenic acid; EPA, eicosapentaenoic acid; DHA, 
docosahexaenoic acid; ND, not detectable. 
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Appendix 4.  The Effect of Feeding Growing Female Rats Different Sources of Omega-3 Polyunsaturated Fatty Acids on the Gonadal 
Adipose Tissue Fatty Acid Profile. 
 Treatments 
Fatty Acid Measurement CO FO KO MO SO  TO 
n-3 PUFA 1.3 ± 0.2
c 
81.7 ± 6.8
a 
21.5 ±2.6
b 
21.6 ± 2.0
b 
9.5 ± 2.8
bc 
13.5 ± 2.4
bc 
ALA (18:3n-3) 1.3 ± 0.2
b 
80.9 ± 6.6
a 
3.1 ± 0.4
b 
5.0 ± 0.4
b 
1.1 ± 0.2
b 
2.0 ± 0.4
b 
EPA (20:5n-3) ND 0.7 ± 0.2
c 
9.7 ± 1.3
a 
5.6 ± 0.9
b 
4.2 ± 1.4
bc 
1.9 ± 0.4
bc 
DHA (22:6n-3) ND 0.07 ± 0.02
c 
8.7 ± 1.2
ab 
10.9 ± 1.0
a 
4.2 ± 1.2
bc 
9.7 ± 2.0
a 
EPA/DHA ND 7.5 ± 2.3
a 
1.1 ± 0.1
b 
0.5 ± 0.1
b 
1.0 ± 0.1
b 
0.2 ± 0.01
b 
n-6 PUFA 107.9 ± 14.1
a 
59.8 ± 5.8
b 
17.0 ± 2.0
c 
21.0 ± 1.8
c 
8.0 ± 1.4
c 
11.6 ± 2.2
c 
LA (18:2n-6) 106.5 ± 13.9
a 
59.4 ± 5.6
b 
15.5 ± 1.9
c 
19.5 ± 1.7
c 
6.5 ± 1.3
c 
8.5 ± 1.6
c 
ARA (20:4n-6) 1.4 ± 0.2
b 
0.5 ± 0.1
b 
1.6 ± 0.2
b 
1.5 ± 0.1
b 
1.4 ± 0.3
b 
3.1 ± 0.7
a 
n-6/n-3 93.6 ± 11.1
a 
0.7 ± 0.02
b 
0.8 ± 0.1
b 
1.0 ± 0.1
b 
1.1 ± 0.2
b 
1.0 ± 0.2
b 
Values are expressed as mean (mg FA/g tissue) ± SEM of n=10 rats/group. Different superscript letters a, b, c within the same rows 
indicate significant differences at P<0.05 by one-way ANOVA followed by Tukey’s test. Abbreviations are: CO, corn oil; FO, 
flaxseed oil; KO, krill oil; MO, menhaden oil; SO, salmon oil; TO, tuna oil; PUFA, polyunsaturated fatty acids; LA, linoleic acid; AA, 
arachidonic acid; ALA, α-linolenic acid; EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid; ND, not detectable. 
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